as on March 7, 2026 at 7:59 am IST
Day's Low
Day's High
2.80%
Downside
0.12%
Upside
52 Week's Low
52 Week's High
5.49%
Downside
58.41%
Upside
Check Elevance Health, Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$64.3B
EPS (TTM)
26.0466
Dividend Yield
1.12%
Quarterly Earnings Growth YOY
0.36%
PE Ratio (TTM)
11.56
Industry PE ratio
17.54844155844156
PEG Ratio
1.1354
EBITDA
9.0B
Revenue (TTM)
199.1B
Profit Margin
2.84%
Return On Equity TTM
13.25%
Track how Elevance Health, Inc P/E has moved over time to understand its valuation trends.
Elevance Health, Inc in the last 5 years
Lowest (10.14x)
September 30, 2025
Today (11.56x)
March 6, 2026
Industry (17.55x)
March 6, 2026
Highest (17.48x)
December 31, 2022
Today’s Price to Earnings Ratio: 11.56x
Compare market cap, revenue, PE, and other key metrics of Elevance Health, Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $64.3B | NA | 11.56 | 2.84% | |
| BUY | $102.5B | 11.41% | 57.96 | 0.44% | |
| BUY | $76.1B | 21.96% | 12.84 | 2.17% | |
| BUY | $264.5B | -16.8% | 22.07 | 2.69% | |
| BUY | $22.1B | -54.74% | 18.63 | 0.92% |
The Elevance Health, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Elevance Health, Inc investment value today
Current value as on today
₹77,410
Returns
Returns from Elevance Health, Inc Stock
Dollar Returns*
₹5,508 (+5.51%)
Based on 26 analysts
84.62%
Buy
15.38%
Hold
0.00%
Sell
Based on 26 analysts, 84.62% of analysts recommend a 'BUY' rating for Elevance Health, Inc. Average target price of $387.85
Get share price movements and forecasts by analysts on Elevance Health, Inc.
What analysts predicted
25.33%UPSIDE
Target Price
$387.85
Current Price
$289.6
Analyzed by
26 Analysts
Target
$387.85
Elevance Health, Inc target price $387.85, a slight upside of 25.33% compared to current price of $289.6. According to 26 analysts rating.
Investment in Elevance Health, Inc Shares on INDmoney has grown by 52.17% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:52.17% versus previous 30 day period
Search interest for Elevance Health, Inc Stock has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 06 March
Fri, 05:38 PM
-CMS plans sanctions on Elevance Health, potentially suspending new enrollments in Medicare Advantage plans due to noncompliance issues.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 3 years, Elevance Health, Inc has experienced a drawdown of -38.0%, however Cvs Health Corporation resisted the overall trend and outperformed by 34.9%
Against Peers
![]()
In the last 1 year, Cvs Health Corporation has given 17.5% return, outperforming this stock by 46.8%
Profit Down
![]()
Elevance Health, Inc. has experienced a decline in net profit over the last four quarters. Starting with a net profit of $2.18 billion, it has decreased significantly to $547 million. This represents an average decrease of 35.3% each quarter.
Revenue Fall
![]()
Elevance Health, Inc. has experienced a decline in revenue over the last two quarters. The revenue decreased from $50.71 billion to $49.74 billion, reflecting an average decrease of 1.9% per quarter.
Price Dip
![]()
In the last 7 days, ELV stock has moved down by -9.5%
| Organisation | Elevance Health, Inc |
| Headquarters | 220 Virginia Avenue, Indianapolis, IN, United States, 46204 |
| Industry | Healthcare |
| CEO | Ms. Gail Koziara Boudreaux |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Charles Morgan Kendrick Jr. | Executive VP & President of Commercial Health Benefits |
Ms. Felicia Farr Norwood | Executive VP & President of Government Health Benefits |
Mr. Scott Wayne Anglin | SVP, Treasurer & Chief Investment Officer |
Mr. Nathan Allen Rich | Vice President of Investor Relations |
Ms. Erin M. Wessling | Executive VP & Chief Legal Officer |
Ms. Julie Goon | Senior Vice President of Public Affairs |
Ms. Gail Koziara Boudreaux | President, CEO & Director |
Mr. Peter David Haytaian Esq. | Executive VP and President of Carelon & CarelonRx |
Mr. Ronald William Penczek | Senior VP, Controller & Chief Accounting Officer |
Mr. Kyle Weber | Chief Strategy Officer & Interim Chief Marketing Officer |
Elevance Health, Inc share price today is $289.6 as on at the close of the market. Elevance Health, Inc share today touched a day high of $289.96 and a low of $281.5.
Elevance Health, Inc share touched a 52 week high of $458.75 on and a 52 week low of $273.71 on . Elevance Health, Inc stock price today i.e. is closed at $289.6,which is 36.87% down from its 52 week high and 5.81% up from its 52 week low.
Elevance Health, Inc market capitalisation is $0.06T as on .
Indian investors can start investing in Elevance Health, Inc (ELV) shares with as little as ₹91.908 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹919.08 in Elevance Health, Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Elevance Health, Inc share’s latest price of $289.6 as on March 7, 2026 at 2:29 am IST, you will get 0.0345 shares of Elevance Health, Inc. Learn more about
fractional shares .